Structure of a new antibiotic, empedopeptin, has been determined.
Structure of a new antibiotic, empedopeptin, has been determined.
It is a cyclic depsipeptide composed of two mol of D-serine and one mol each of ;i-hydroxytetradecanoic acid, L-arginine, D-and L-proline, L-3-hydroxyproline and D-and L-;:-hydroxyaspartic acid. The sequence of these moieties was established by partial hydrolysis and mass spectral analysis of the antibiotic.
Empedopeptin is a new peptide antibiotic produced by a strain of Empedobacter. The taxonomy of the producing organism, the production, isolation and properties of the antibiotic were described in the preceding paper1). The experiments presented in this paper revealed that empedopeptin has the following structure:
General Structural Characteristics
Empedopeptin did not exhibit any absorption in the UV and visible regions. The molecular formula of C49H79N11O19 was assigned for the antibiotic on the basis of microanalysis, molecular weight determination (1,270 by osmometry, 1,250 by titration) and amino acid analysis. Empedopeptin gave a positive response to the SAKGUCHI reagent but was negative in the ninhydrin and anthrone tests. The IR spectrum of empedopeptin showed a polyhydroxyl absorption at around 3350 cm-1, an ester carbonyl at 1735 cm-1 and a broad, strong amide carbonyl band at around 1620 ~ 1680 cm-1.
The NMR spectrum indicated the presence of a triplet methyl and several methylene and methine protons. No aromatic or double bond proton signals were observed in the spectrum. Potentiometric titration indicated the presence of two carboxylic groups (pKa': 3.0 and 4.1) and a guanidino group (pKa': > 11.0) in empedopeptin.
Complete Acid Hydrolysis of Empedopeptin
Empedopeptin was hydrolyzed with 6 N HCl in a sealed tube at 105°C for 16 hours. The reaction mixture was shaken with ethyl ether to extract an acidic lipophilic product (compound VI). The aqueous layer containing amino acid fragments was chromatographed on a column of Dowex 50W X4
THE JOURNAL OF ANTIBIOTICS VOL. XXXVII NO. 9 using increasing concentrations of hydrochloric acid (0.05 ~ 3.0 N) as eluant. Five amino acids, I, II, III, IV and V were eluted in that order and each amino acid was isolated as its crystalline hydrochloride.
Three of them, amino acids III, IV and V, were identified as serine, proline and arginine, respectively, by their physico-chemical data.
The IR and NMR spectra of amino acid I were consistent with those of threo-;s-hydroxyaspartic acid which has been reported as an antimicrobial metabolite produced by Arthrinium phaeospermum and Streptomyces sp.2). The identity was established by direct comparison with an authentic sample.
Amino acid II was determined to be 3-hydroxyproline3) by its physico-chemical and spectral data.
The small J2,3 value (1.2 Hz) observed for II indicated a trans configuration for the amino acid. It was identified as trans-L-3-hydroxyproline by direct comparison with an authentic specimen prepared by acid hydrolysis of telomycin4).
The molar ratio of these amino acids determined by an amino acid analyzer is shown in Table 1 .
The chirality of each amino acid was assigned from its optical rotational value together with the result of the amino acid oxidase reaction. The IR spectrum of I was superimposable with that of D,L-threof-hydroxyaspartic acid but was different from that of either the D or L form2). The acidic, lipophilic compound VI was treated with diazomethane to give a methyl ester which was purified by silica gel chromatography.
The methyl ester showed the highest ion peak at m/z 257 (M+-1) in the mass spectrum, suggesting a hydroxy C14 fatty acid ester. This, together with the NMR spectrum, indicated that VI was 3-hydroxytetradecanoic acid. products by ethyl ether extraction, the hydrolysate was chromatographed on Dowex 50W X4 to obtain four major peptide fragments, VII, VIII, IX and X. Quantitative amino acid analysis established the amino acid composition of peptides VII (Ser, 3-OH-Pro, and 2 mol of -OH-Asp), VIII (Ser, 9-OH-Asp and 3-OH-Pro), IX (Ser, Pro, Arg and 9-OH-Asp) and X (Ser, Pro and Arg). The chirality of these amino acids was assigned based on the specific rotation of each amino acid which was isolated by complete acid hydrolysis of the individual peptides. The N-terminal and C-terminal amino acids of these peptides were determined by the DNP method7) and the Dakin-West degradation5), respectively. Tetrapeptides VII and IX were degraded with phenyl isothiocyanate following EDMAN's method5) with slight modifications. These studies established the order of amino acid linkages as illustrated in Fig. 1. Thus, a partial structure (XI) of empedopeptin was deduced as shown below:
The acidic, solvent-extractable products obtained above were chromatographed on silica gel to yield a homogeneous crystalline compound XII. Compound XII displayed an amide carbonyl band at 1625 cm-1 in the IR spectrum and, upon complete acid hydrolysis, afforded D-proline and the C14 fatty acid VI. Therefore, the structure of XII was established as 3-hydroxytetradecanoyl-D-proline.
The methyl ester of XII obtained by treatment with diazomethane showed the molecular ion peak at in/z 355 and several fragment ions which supported the assigned structure.
Mild Alkaline Hydrolysis
When treated with 0. 
The above peptide sequence was verified by the mass spectra of empedopeptin and empedopeptinic acid. Although molecular ions or larger peptide ions were not detected, the spectra clearly indicated the sequence of fatty acid (VI)-*Pro-->Ser-->Pro. As shown in Table 2 , fragment ions of empedopeptin were observed to arise from the hydroxy acid after dehydration in the mass spectrometer. On the other hand, the corresponding ions of empedopeptinic acid appeared 18 a.m.u. higher than those of empedopeptin, being consistent with the hydrated structure. This information, together with the carbonyl band observed at 1735 cm-1, indicated that the hydroxyl group of VI should be esterified to form a cyclic lactone in empedopeptin6). As discussed earlier, the newly generated carboxyl group of empedopeptinic acid had pKa' 2.4 which was attributable to the a-carboxyl group of C-terminal L hydroxyaspartic acid. Hence, the total structure of empedopeptin was determined as shown at the beginning of this paper. The presence of many hydroxyl groups is another structural feature of empedopeptin which makes the antibiotic highly soluble in water.
Experimental
Thin-layer chromatography (TLC) was performed on silica gel plate (Kieselgel 60F254, Merck) using the solvent systems shown below: 
Mild Acid Hydrolysis of Empedopeptin

Empedopeptin
(1.5 g) was hydrolyzed with 300 ml of 6 N HCl at 37`C for 72 hours. The solution was shaken with two 150 ml-portions of ethyl ether to extract lipophilic products.
The aqueous layer OF ANTIBIOTICS VOL. XXXVII NO. 9 was concentrated in vacuo to a sticky residue (1.136 g) which was applied on a column of Dowex 50W X4 (H+ form, ¢1.5 x 60 cm). Elution was performed with an increasing concentration of HCl and the eluate monitored by ninhydrin and SAKAGUCHI reagents and TLC (S-101 and S-126). Peptide VII (70 mg) was eluted first with 0.05 N HCl followed by VIII (173 mg) with 0.07 N HCl and IX (251 mg) with 2 N HCl. Peptide X (159 mg) was eluted with 3 N HCl solution. Amino acid contents of these peptides were determined by the amino acid analyzer after complete acid hydrolysis with 6 N HCl.
The lipophilic products obtained in the above hydrolysis were treated with a large excess of diazomethane in ether. After removal of the solvent, the residue was charged on a silica gel column (61.5 x 20 cm) which was eluted with benzene -EtOAc (2: 1). The elution was followed by TLC (SD-112) and appropriate fractions were evaporated in vacuo to give 64 mg of methyl ester of XII. The amino acids were isolated by Dowex 50W X4 chromatography and the chirality of each amino acid was determined by its specific rotational value as shown below.
Determination of N-Terminal Amino Acids of Peptides VII, VIII, IX and X7) An aqueous solution (1 ml) of each of the peptides (20 mg) and sodium bicarbonate (30 mg) was mixed with 2 ml of 5 % dinitrofluorobenzene in EtOH and the mixture stirred for 2 hours in a dark room. The solution was diluted with H.O (50 ml), washed with benzene to remove excess dinitrofluorobenzene and dinitrophenol, and then extracted with 1-BuOH at pH 2.0. Evaporation of the 1-BuOH extract afforded a yellow DNP-peptide which was purified by preparative TLC using solvent system of PL-111. The pure peptide was hydrolyzed with 6 N HCI and the DNP-amino acid produced was identified by comparison with an authentic sample by TLC and NMR. Peptide VII (DNP-I), VIII (DNP-Ser), IX (DNP-Ser) and X (DNP-Ser).
EDMAN Degradation of Peptides VII and IX8) Phenyl isothiocyanate (0.2 ml) was added to a solution of each of the peptides (5 mg) dissolved in 1.6 ml of dimethylallylamine buffer (pH 9.5). The mixture was warmed at 45°C for one hour under nitrogen atomosphere and then excess phenyl isothiocyanate removed by extraction with benzene (1 ml x 4). The aqueous layer was concentrated to dryness and the residue was dried over phosphorous The residue was taken up in 0.2 ml of trifluoroacetic acid and the solution kept at 40'C for 40 minutes under nitrogen atomosphere.
After evaporation of trifluoroacetic acid, the residue was dissolved in 1 ml of 0.1 N HCl and the solution extracted with four 1 ml-portions of ether.
Evaporation of the ethereal extracts afforded phenylthiohydantoin (PTH) amino acid. The aqueous layer was lyophilized to give a white solid of the remaining peptide which was used for the next cycle of EDMAN degradation.
A part of the peptide fragment was hydrolyzed and the amino acids produced were analyzed by TLC.
The PTH-amino acid obtained in each cycle of the reaction and the constituent amino acids of the remaining peptide fragments were determined as shown below.
